Abou Nader N, Levasseur A, Zhang X, Boerboom D, Nagano MC, Boyer A (2019) Yes-associated protein expression in germ cells is dispensable for spermatogenesis in mice. Genesis 57:e23330. https://doi.org/10.1002/dvg.23330

Article  PubMed  Google Scholar 

Abou Nader N, Ménard A, Levasseur A, St-Jean G, Boerboom D, Zamberlam G, Boyer A (2022) Targeted disruption of Lats1 and Lats2 in mice impairs testis development and alters somatic cell fate. Int J Mol Sci. https://doi.org/10.3390/ijms232113585

Article  PubMed  PubMed Central  Google Scholar 

Bevers TB, Anderson BO, Bonaccio E, Buys S, Daly MB, Dempsey PJ, Farrar WB, Fleming I, Garber JE, Harris RE et al (2009) NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis. J Natl Compr Canc Netw 7:1060–1096. https://doi.org/10.6004/jnccn.2009.0070

Article  PubMed  Google Scholar 

Britschgi A, Duss S, Kim S, Couto JP, Brinkhaus H, Koren S, De Silva D, Mertz KD, Kaup D, Varga Z et al (2017) The hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature 541:541–545. https://doi.org/10.1038/nature20829

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brodowska K, Al-Moujahed A, Marmalidou A, Meyer Zu Horste M, Cichy J, Miller JW, Gragoudas E, Vavvas DG (2014) The clinically used photosensitizer Verteporfin (VP) inhibits YAP-TEAD and human retinoblastoma cell growth in vitro without light activation. Exp Eye Res 124:67–73. https://doi.org/10.1016/j.exer.2014.04.011

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bunney PE, Zink AN, Holm AA, Billington CJ, Kotz CM (2017) Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet. Physiol Behav 176:139–148. https://doi.org/10.1016/j.physbeh.2017.03.040

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cha YJ, Bae SJ, Kim D, Ahn SG, Jeong J, Koo JS, Yoo TK, Park WC, Lee A, Yoon CI (2021) High nuclear expression of Yes-associated protein 1 correlates with metastasis in patients with breast cancer. Front Oncol 11:609743. https://doi.org/10.3389/fonc.2021.609743

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen YA, Lu CY, Cheng TY, Pan SH, Chen HF, Chang NS (2019) Ww domain-containing proteins YAP and TAZ in the Hippo pathway as key regulators in stemness maintenance, tissue homeostasis, and tumorigenesis. Front Oncol 9:60. https://doi.org/10.3389/fonc.2019.00060

Article  PubMed  PubMed Central  Google Scholar 

Chen M, Zhong L, Yao SF, Zhao Y, Liu L, Li LW, Xu T, Gan LG, Xiao CL, Shan ZL, Liu BZ (2017) Verteporfin inhibits cell proliferation and induces apoptosis in human leukemia NB4 cells without light activation. Int J Med Sci 14:1031–1039. https://doi.org/10.7150/ijms.19682

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng H, Zhang Z, Rodriguez-Barrueco R, Borczuk A, Liu H, Yu J, Silva JM, Cheng SK, Perez-Soler R, Halmos B (2016) Functional genomics screen identifies YAP1 as a key determinant to enhance treatment sensitivity in lung cancer cells. Oncotarget 7:28976–28988. https://doi.org/10.18632/oncotarget.6721

Article  PubMed  Google Scholar 

Coto-Llerena M, Tosti N, Taha-Mehlitz S, Kancherla V, Paradiso V, Gallon J, Bianco G, Garofoli A, Ghosh S, Tang F et al (2021) Transcriptional enhancer factor domain family member 4 exerts an oncogenic role in hepatocellular carcinoma by Hippo-independent regulation of heat shock protein 70 family members. Hepatol Commun 5:661–674. https://doi.org/10.1002/hep4.1656

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai M, Yan G, Wang N, Daliah G (2021) In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. Nat Commun 12:3055. https://doi.org/10.1038/s41467-021-23316-4

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eckert D, Nettersheim D, Heukamp LC, Kitazawa S, Biermann K, Schorle H (2008) TCam-2 but not JKT-1 cells resemble seminoma in cell culture. Cell Tissue Res 331:529–538. https://doi.org/10.1007/s00441-007-0527-y

Article  CAS  PubMed  Google Scholar 

Feng J, Gou J, Jia J, Yi T, Cui T, Li Z (2016) Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer. OncoTargets Ther 9:5371–5381. https://doi.org/10.2147/ott.S109979

Article  CAS  Google Scholar 

Fu J, McGrath NA, Lee J, Wang X, Brar G, Xie C (2022) Verteporfin synergizes the efficacy of anti-PD-1 in cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases Int HBPD INT 21:485–492. https://doi.org/10.1016/j.hbpd.2022.03.006

Article  CAS  Google Scholar 

Guo Y, Luo J, Zou H, Liu C, Deng L, Li P (2022) Context-dependent transcriptional regulations of YAP/TAZ in cancer. Cancer Lett 527:164–173. https://doi.org/10.1016/j.canlet.2021.12.019

Article  CAS  PubMed  Google Scholar 

Han H, Yang B, Nakaoka HJ, Yang J, Zhao Y, Le Nguyen K, Bishara AT, Mandalia TK, Wang W (2018) Hippo signaling dysfunction induces cancer cell addiction to YAP. Oncogene 37:6414–6424. https://doi.org/10.1038/s41388-018-0419-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hasegawa T, Sugihara T, Hoshino Y, Tarumoto R, Matsuki Y, Kanda T, Takata T, Nagahara T, Matono T, Isomoto H (2021) Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein survivin in a light-independent manner. Oncol Lett 22:703. https://doi.org/10.3892/ol.2021.12964

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang Y, Ahmad US, Rehman A, Uttagomol J, Wan H (2022) Yap inhibition by verteporfin causes downregulation of desmosomal genes and proteins leading to the disintegration of intercellular junctions. Life (Basel). https://doi.org/10.3390/life12060792

Article  PubMed  PubMed Central  Google Scholar 

Jacobs LA, Vaughn DJ (2012) Hypogonadism and infertility in testicular cancer survivors. J Nat Comprehens Cancer Network : JNCCN 10:558–563. https://doi.org/10.6004/jnccn.2012.0053

Article  Google Scholar 

Jeong SB, Das R, Kim DH, Lee S, Oh HI, Jo S, Lee Y, Kim J, Park S, Choi DK et al (2022) Anticancer effect of verteporfin on non-small cell lung cancer via downregulation of ANO1. Biomed Pharmacother 153:113373. https://doi.org/10.1016/j.biopha.2022.113373

Article  CAS  PubMed  Google Scholar 

de Jong J, Stoop H, Gillis AJ, Hersmus R, van Gurp RJ, van de Geijn GJ, van Drunen E, Beverloo HB, Schneider DT, Sherlock JK et al (2008) Further characterization of the first seminoma cell line TCam-2. Genes Chromosomes Cancer 47:185–196. https://doi.org/10.1002/gcc.20520

Article  CAS  PubMed  Google Scholar 

Kjærner-Semb E, Ayllon F, Kleppe L, Sørhus E, Skaftnesmo K, Furmanek T, Segafredo FT, Thorsen A, Fjelldal PG, Hansen T et al (2018) Vgll3 and the Hippo pathway are regulated in Sertoli cells upon entry and during puberty in Atlantic salmon testis. Sci Rep 8:1912. https://doi.org/10.1038/s41598-018-20308-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Levasseur A, Paquet M, Boerboom D, Boyer A (2017) Yes-associated protein and WW-containing transcription regulator 1 regulate the expression of sex-determining genes in Sertoli cells, but their inactivation does not cause sex reversal. Biol Reprod 97:162–175. https://doi.org/10.1093/biolre/iox057

Article  PubMed  Google Scholar 

Liu X, Quan J, Shen Z, Zhang Z, Chen Z, Li L, Li X, Hu G, Deng X (2022) Metallothionein 2A (MT2A) controls cell proliferation and liver metastasis by controlling the MST1/LATS2/YAP1 signaling pathway in colorectal cancer. Cancer Cell Int 22:205. https://doi.org/10.1186/s12935-022-02623-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA, Liu JO, Pan D (2012) Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 26:1300–1305. https://doi.org/10.1101/gad.192856.112

Article  CAS  PubMed  PubMed Central